Medscape2d
Management of Choroidal Neovascularization in Myopic Macular Degeneration
Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...
Monthly Prescribing Reference1d
Izervay Label Update Removes Limit on Treatment Duration for Geographic Atrophy
The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...
Pharmabiz1d
US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy
US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...
U.S. FDA Approves Expanded Label for Astellas' IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY™ ...
modernretina1d
A new technique to estimate melanocytic choroidal tumor thicknesses without B-scan ultrasonography
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Healio11d
VIDEO: Multimodal imaging essential for geographic atrophy management
In this Healio Video Perspective from Retina 2025, Roger A. Goldberg, MD, MBA, discusses the role of multimodal imaging in geographic atrophy in the era of complement inhibitors.Imaging confirms the ...
Medscape18d
Management of Choroidal Neovascularization in Myopic Macular Degeneration
Expert Rev Ophthalmol. 2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic ...